#Hong Kong #Sisram Medical #Titanium Prime #Alma PrimeX

Sisram Medical Launches Titanium Prime Treatment Concept in Hong Kong SAR

On August 4, 2026, Sisram Medical Ltd, a leader in global wellness, took a significant step in aesthetic treatments by unveiling its Titanium Prime treatment concept in Hong Kong SAR. This innovative offering integrates two of the company's flagship Energy-Based Device (EBD) platforms, the Alma PrimeX and the Soprano Titanium Special Edition, enhancing their portfolio of aesthetic solutions available locally.

Uniting Technologies for Superior Results

The Titanium Prime treatment concept is powered by the state-of-the-art Tri-Energy Synergy technology, which harmonizes laser, radiofrequency, and ultrasound modalities using the proprietary BTS² methodology. This layered approach targets different tissue depths, aiming to achieve multidimensional outcomes for anti-aging and skin rejuvenation.

By leveraging the distinct strengths of the Alma PrimeX and Soprano Titanium Special Edition devices, the treatment protocol caters to varied aesthetic needs. It comprehensively addresses aspects concerning skin texture, firmness, and facial contours. Each treatment is highly personalized, reflecting a systematic approach to facial rejuvenation that adapts to the unique requirements of each patient.

Adapting to Market Trends

In a rapidly evolving medical aesthetic landscape, there has been a notable shift in preference from standalone devices to integrated, multi-technology solutions that deliver customized regimens. This trend is increasingly embraced by both clinics and patients who seek innovative solutions that combine different technologies for enhanced effectiveness. Sisram’s new integrated model not only broadens the clinical applications but also enhances the commercial value of its offerings.

The Titanium Prime concept is designed to empower partner clinics to create distinct signature treatments, thereby fortifying their competitive edge while maximizing financial returns through synergistic product combinations. The successful implementation of this concept in Hong Kong is projected to serve as a benchmark for developing tailored treatment strategies in key APAC markets, thereby solidifying Sisram’s strategic positioning across the region.

Strategic Vision and Future Directions

Eyal Ben David, CEO of Sisram Medical, emphasized that the launch of Titanium Prime represents a pivotal moment in the company's evolution from a traditional device supplier to a comprehensive platform that integrates multiple technologies. He stated, “With the unified approach under Titanium Prime, we are responding to the robust demand for personalized and layered anti-aging solutions in Hong Kong's premium aesthetic market. This innovation elevates patient outcomes and strengthens the engagement of our clinic partners.”

He elaborated that Hong Kong SAR is a thriving and sophisticated market with a high propensity for adopting innovative EBD solutions, non-invasive treatments, and customized combination therapies. According to him, this market will play a critical role in incubating and scaling innovative concepts across the APAC region.

In the future, Sisram is committed to further enhancing the synergies among its core technologies and product lines while expanding its customer reach across the region. The company aims to continuously upgrade its service capabilities to ensure sustained high-quality growth in the APAC market.

About Sisram Medical Ltd

Sisram Medical Ltd (1696.HK) has established itself as a frontrunner in the global medical aesthetics field, backed by over 25 years of expertise in Energy-Based Devices. Their legacy of innovation and clinical excellence equips them to provide award-winning products that redefine safety, effectiveness, and personalized aesthetic care across more than 110 countries. Being majority-owned by Fosun Pharma, Sisram has been publicly traded on the Hong Kong Stock Exchange since September 2017.

For those interested in learning more about Sisram Medical or its innovative offerings, please visit www.sisram-medical.com.